Picture of Nykode Therapeutics ASA logo

NYKD — Nykode Therapeutics ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Nykode Therapeutics Q4 Operating Loss At $8.1 Million

Feb 25 (Reuters) - Nykode Therapeutics ASA NYKD.OL:

Q4 OPERATING LOSS USD 8,090 THOUSAND

Q4 NET LOSS USD 7,997 THOUSAND

Q4 TOTAL OPERATING EXPENSES USD 8,090 THOUSAND

Source text: ID:nObiynr4Pa

Further company coverage: NYKD.OL

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Nykode Therapeutics ASA

See all news